CITIGROUP INC - JOUNCE THERAPEUTICS INC ownership

JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 106 filers reported holding JOUNCE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.23 and the average weighting 0.5%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of JOUNCE THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$472
-84.3%
425
-69.7%
0.00%
Q3 2022$3,000
-98.2%
1,402
-97.5%
0.00%
Q2 2022$170,000
+900.0%
56,193
+2128.1%
0.00%
Q1 2022$17,000
-79.3%
2,522
-74.5%
0.00%
Q4 2021$82,000
+74.5%
9,872
+55.0%
0.00%
Q3 2021$47,000
+46.9%
6,369
+36.3%
0.00%
Q2 2021$32,000
+52.4%
4,673
+132.5%
0.00%
Q1 2021$21,000
-32.3%
2,010
-54.7%
0.00%
Q4 2020$31,000
+342.9%
4,434
+434.9%
0.00%
Q3 2020$7,000
-66.7%
829
-72.5%
0.00%
Q2 2020$21,000
-25.0%
3,013
-48.5%
0.00%
Q1 2020$28,000
-36.4%
5,847
+16.4%
0.00%
Q4 2019$44,000
+175.0%
5,022
+6.0%
0.00%
Q3 2019$16,000
-23.8%
4,736
+14.6%
0.00%
Q2 2019$21,000
-19.2%
4,132
-3.1%
0.00%
Q1 2019$26,000
+30.0%
4,266
-29.6%
0.00%
Q4 2018$20,000
-9.1%
6,060
+75.0%
0.00%
Q3 2018$22,000
-82.9%
3,463
-79.5%
0.00%
Q2 2018$129,000
-63.1%
16,868
+8.0%
0.00%
Q1 2018$350,000
+75.0%
15,624
-0.3%
0.00%
Q4 2017$200,000
+545.2%
15,675
+679.9%
0.00%
Q3 2017$31,000
+6.9%
2,010
-3.5%
0.00%
Q2 2017$29,000
-79.3%
2,082
-67.3%
0.00%
Q1 2017$140,0006,3640.00%
Other shareholders
JOUNCE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
TRV GP II, LLC 9,200,349$64,402,00044.86%
TRV GP III, LLC 3,048,780$21,342,0001.83%
SILVERARC CAPITAL MANAGEMENT, LLC 406,665$2,847,0001.65%
Sofinnova Investments, Inc. 925,280$6,477,0000.39%
Omega Fund Management, LLC 334,965$2,345,0000.35%
Yorktown Management & Research Co Inc 49,200$344,0000.31%
Woodline Partners LP 940,902$6,586,0000.18%
HUSSMAN STRATEGIC ADVISORS, INC. 51,000$357,0000.09%
HORIZON FINANCIAL SERVICES, LLC 12,005$84,0000.08%
Gyon Technologies Capital Management, LP 26,893$188,0000.06%
View complete list of JOUNCE THERAPEUTICS INC shareholders